A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.
about
Pharmacological interventions for drug-using offendersInterventions for drug-using offenders with co-occurring mental illnessPharmacological interventions for drug-using offendersPsychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependencePharmacotherapy for opioid dependence in jails and prisons: research review update and future directionsOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaPre-incarceration police harassment, drug addiction and HIV risk behaviours among prisoners in Kyrgyzstan and Azerbaijan: results from a nationally representative cross-sectional study.The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central AsiaMental health of prisoners: prevalence, adverse outcomes, and interventionsRetention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersConfronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from MalaysiaCost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone“I know if I drink I won’t feel anything”: substance use relapse among depressed women leaving prisonA randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entryThe effectiveness of opioid maintenance treatment in prison settings: a systematic review.Drug use and opioid substitution treatment for prisoners.Ukrainian prisoners and community reentry challenges: implications for transitional care.Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviourCorrelates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners.HIV treatment in US prisons.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.Medication-assisted treatment for opioid dependence: making a difference in prisons.Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment.Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia.Linkage to care for HIV-infected heterosexual men in the United StatesPrevention of HIV infection among injection drug users in resource-limited settings.Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users.HIV-related research in correctional populations: now is the time.Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study.
P2860
Q24187352-3B02B59B-92F3-46D3-BB6C-D161EE8CB835Q24201247-9152F9AC-6A75-4787-8444-58F2F2CA4697Q24201693-FAAE8DC0-27E3-44B1-978C-06FCB595DD1BQ24235930-DA389993-A906-4693-997D-63C495D7D65AQ26746195-9B050BE5-03DB-40C6-B491-C2E1B6826360Q26778626-1E31C1CB-4821-4B39-990E-F1198D0C7740Q27300526-D1068DF8-7514-4008-889B-DC87DDBE8EE4Q28077903-0DF01BEC-251E-4077-81DA-47086F74F129Q28078914-214B8097-289D-492F-9E5C-9FE6A93EDFD2Q28729018-8938BA62-5A74-4768-BF1C-CBB0874F35CAQ30250218-108C5877-D4DC-48E2-8D07-FEB445456BF7Q30253083-B36BC419-957B-4121-85C7-E065B5B6171BQ30751889-15321369-430C-49F5-9D26-742034CF112FQ33819391-CC839490-94BA-4E65-A342-9CE57B159E91Q33844064-45530221-B15A-4B7A-956C-348F2D85A7EAQ33898696-DA213937-7098-4460-B898-B847626EFFB2Q33959173-C508A9BF-CF47-4934-B54B-BBFA2BF0CACFQ34030894-DD83BEFF-154E-4485-90FB-169C0F13A4EDQ34033794-9CF298E5-6600-42F7-8467-59A56603311FQ34053733-91B05342-A39A-4C0B-AB6E-2066164C2AD1Q34068801-9B0948CE-FCF4-456F-9CD3-CEE652280DE6Q34105570-096B2D9E-3B68-476A-AFD6-4390E58032CDQ34169506-F314E15B-01D9-4BA0-950D-B134E6015C2DQ34193216-2572274B-226D-450E-95F3-C536FC3CA391Q34472876-8B3ECF37-89C2-44B8-BE6B-EE0F7B741CC2Q34478687-8DDBB045-9B08-4A9D-B5AD-6B495CBB84B4Q34589284-C45BF2F4-19F8-4DB5-807C-9C5F4873ECCEQ34676524-ADE79D81-D2D8-4205-9B19-DE9431B90BEFQ34817072-6B278F77-8CE9-4221-A1A4-502347DAA07FQ34870554-B9428B97-2559-4053-8532-1376626D4A97Q34890135-4FE557FF-4032-44AF-9405-125F5313B715Q34980145-0F385409-4ACD-4135-8F3B-8DF6FB6E1928Q35019900-AEBC0882-0C60-4C8F-8BF7-1409AE98B9DDQ35043964-86ADD262-A64C-4C07-B1DD-B26997BA051BQ35088386-EFA09D3A-60E2-4FFF-B8D5-C20D8EADD271Q35090939-0EE2B398-0DA4-4631-AE13-37A2C674BE51Q35164557-63665AD6-0848-40FD-B1DD-8F7FCA79086DQ35395665-48656350-B7DA-441F-A96F-F393F50B7282Q35528959-4D4DD95D-41E3-45C6-B577-161CE36A3211Q35610989-E42DB855-1D77-4654-B429-4E790217D262
P2860
A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A randomized clinical trial of ...... ults at 12 months postrelease.
@ast
A randomized clinical trial of ...... ults at 12 months postrelease.
@en
A randomized clinical trial of ...... ults at 12 months postrelease.
@nl
type
label
A randomized clinical trial of ...... ults at 12 months postrelease.
@ast
A randomized clinical trial of ...... ults at 12 months postrelease.
@en
A randomized clinical trial of ...... ults at 12 months postrelease.
@nl
prefLabel
A randomized clinical trial of ...... ults at 12 months postrelease.
@ast
A randomized clinical trial of ...... ults at 12 months postrelease.
@en
A randomized clinical trial of ...... ults at 12 months postrelease.
@nl
P2093
P2860
P1476
A randomized clinical trial of ...... ults at 12 months postrelease.
@en
P2093
Kevin E O'Grady
Michael S Gordon
Robert P Schwartz
Terrence T Fitzgerald
Timothy W Kinlock
P2860
P304
P356
10.1016/J.JSAT.2009.03.002
P577
2009-03-31T00:00:00Z